Dr Reddy’s Knocked Back On Rituximab In US
Biosimilar Rival To Rituxan Receives Complete Response Letter From FDA
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.